Related Experiment Video
Updated: Sep 27, 2026
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
Advances in understanding and management of retinopathy of prematurity
1Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.
Insights
Retinopathy of prematurity (ROP) understanding and treatment have evolved significantly. Current research focuses on advanced imaging, targeted therapies, and understanding cellular interactions to improve visual outcomes in premature infants.
Area of Science:
- Ophthalmology
- Neonatology
- Developmental Biology
Background:
- Retinopathy of prematurity (ROP) understanding has evolved over 70 years.
- ROP presentation varies globally, especially with increasing survival of extremely premature infants.
- Historical context includes retrolental fibroplasia linked to high oxygenation.
Purpose of the Study:
- To review advancements in ROP diagnosis and treatment.
- To explore novel imaging techniques for retinal assessment.
- To investigate new therapeutic strategies for ROP.
Main Methods:
- Evaluation of new retinal imaging methods.
- Assessment of diagnostic criteria for severe ROP.
- Review of emerging treatments targeting vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), and erythropoietin signaling.
- Study of oxidative stress and cellular interactions (progenitor, neurovascular, glial vascular).
Main Results:
- New imaging and diagnostic tools are under evaluation.
- Therapeutic approaches aim to promote physiologic vascular development and repair.
- Research is exploring ways to inhibit abnormal blood vessel growth (vasoproliferation).
- Understanding of oxidative stress and cellular mechanisms is advancing.
Conclusions:
- Significant progress has been made in ROP management.
- Ongoing research promises improved visual and neural outcomes for affected infants.
- Future directions involve personalized treatments based on molecular signaling and cellular interactions.
Abstract:
The understanding, diagnosis, and treatment of retinopathy of prematurity have changed in the 70 years since the original description of retrolental fibroplasia associated with high oxygenation. It is now recognized that retinopathy of prematurity differs in appearance worldwide and as ever smaller and younger premature infants survive. New methods are being evaluated to image the retina, diagnose severe retinopathy of prematurity, and determine windows of time for treatment to save eyes and improve visual and neural outcomes. New treatments to promote physiologic retinal vascular development, vascular repair, and inhibit vasoproliferation by regulating proteins involved in vascular endothelial growth factor, insulin-like growth factor, or erythropoietin signaling. Reducing excessive oxidative/nitrosative stress and understanding progenitor cells and neurovascular and glial vascular interactions are being studied.
